14422-50-5

Upstream product

• 635-21-2 5-chloroanthranilic acid 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 1247823-71-7 5-chloro-2-({[4-(diphenylmethyl)piperazin-1-yl]acetyl}amino)benzoic acid 
• 1247823-59-1 5-chloro-2-{[N-(diphenylmethyl)glycyl]amino}benzoic acid 
• 1247823-55-7 5-chloro-2-{[N-(4’-fluoro-4-methylbiphenyl-3-yl)glycyl]amino}benzoic acid 
• 1051114-49-8 5-chloro-2-(2-(4-oxo-3-phenethyl-3,4-dihydroquinazolin-2-ylthio)acetamido)benzoic acid 

Relevant academic research and scientific papers

Design and synthesis of quinazolinone derivatives as anti-inflammatory agents: Pharmacophore modeling and 3D QSAR studies

A series of 36 novel substituted quinazolinone derivatives were synthesized and evaluated for their antiinflammatory activity by carrageenan induced paw inflammation model. The ability of these compounds to inhibit cyclooxygenase (COX-1 and 2) enzyme has

Plasminogen Activator Inhibitor-1 Inhibitor

The present invention provides a novel compound having plasminogen activator inhibitor-1 inhibitory activity, and an inhibitor of PAI-1 comprising the compound as an active ingredient. The present invention also provides a pharmaceutical composition having an inhibitory action on PAI-1 activity and being efficacious in the prevention and treatment of various diseases whose onset is associated with PAI-1 activity.

The Vilsmeier cyclisation of azides: A novel route towards the synthesis of imidazo[1,2-a]quinazoline-1,5-diones

Imidazo[1,2-a]quinazoline-1,5-diones 2a-d have been prepared in one pot from 2-azido-N-(2-carboxyaryl)acetamides 1a-d.

Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their preparation, and use as anti-retroviral agents

The present invention relates to substituted (2-oxo-1-benzimidazolinyl)-piperidines of the general formula (I) STR1 in which the substituents have the meaning indicated in the description, to processes for their preparation and to their use as antiretrovi